A systematic review update of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists.

Схожие документы

• A systematic review update of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists.
  по: Robinson, и др.
  Опубликовано: (2002-01-01)
• Thrombocytopenia induced by glycoprotein (GP) IIb-IIIa antagonists: about two cases
  по: Salma Abdeladim, и др.
  Опубликовано: (2021-01-01)
• Using flow cytometry to monitor glycoprotein IIb-IIIa activation
  по: Andrew L. Frelinger
  Опубликовано: (2018-10-01)
• Inibidores da glicoproteína IIb/IIIa na prática clínica Inhibidores de la glicoproteína IIb/IIIa en la práctica clínica Glycoprotein IIb/IIIa inhibitors in clinical practice
  по: Felipe Maia, и др.
  Опубликовано: (2009-01-01)
• Glycoprotein IIb-IIIa and the translocation of Rap2B to the platelet cytoskeleton.
  по: Torti, M, и др.
  Опубликовано: (1994)